BIARYL SPIROAMINOOXAZOLINE ANALOGUES AS ALPHA2C ADRENERGIC RECEPTOR MODULATORS

摘要

In its many embodiments, the present invention provides a novel class of biaryi spiroaminooxazoline analogues as modulators ofα2C adrenergic receptor agonists, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more conditions associated with theα2C adrenergic receptors using such compounds or pharmaceutical compositions.